Kahn and his colleagues found out that, in a total of 5917 patients with endometrial cancer, 1044 patients were tested MLH1 immunohistochemistry (IHC) absent, of which 86.3% were considered to be due to the presence of DNA methylation in MLH1 [25]. The gene discussed is MLH1; the disease is endometrial cancer.